PTC Therapeutics PTCT Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's quick ratio?
- PTC Therapeutics (PTCT) reported quick ratio of 2.4× in Q1 2026.
- How has PTC Therapeutics's quick ratio changed year-over-year?
- PTC Therapeutics's quick ratio decreased by 38.8% year-over-year, from 3.9× to 2.4×.
- What is the long-term trend for PTC Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), PTC Therapeutics's quick ratio has grown at a -12.3% compound annual growth rate (CAGR), from 4.4× to 2.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.